Quotes

Back To Menu

HDFC Pharma and Healthcare Fund - Regular (G) Equity - Pharma
INVEST

Plan: OPEN | Option: Growth | Nikhil Mathur

20 Dec 24 | 12:00 AM

16.45 -0.21 (-1.24%)

  • Outperforms

    51.93%

    Return (1Y)

    beaten BSE Healthcare TRI by 3.62%

  • Less Volatile

    0.81%

    Standard Deviation (1Y)

    Lower Equity - Pharma by -0.20%

  • Inconsistent

    2/5

    Months

    Has underperformed Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year HDFC Pharma and Healthcare Fund - Regular (G), has underperformed by 3.62% (CAGR difference)

51.93%

Outperforms

This is Alpha

Performance Chart for Rs

Invested in

22 Dec 2023

Risk

In last 1 year , the volatility of HDFC Pharma and Healthcare Fund - Regular (G) is Lower than by -0.20%

0.81%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 2 out of Last 5 Months, i.e 40% of the times It underperformed its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition